Stock AMGN34 AMGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Amgen Inc. Sao Paulo

Equities

AMGN34

BRAMGNBDR004

Market Closed - Sao Paulo
Other stock markets
 17:42:47 21/06/2024 BST 		5-day change 1st Jan Change
60.36 BRL +0.43% Intraday chart for Amgen Inc. +5.49% +20.84%
06-21 US FDA approves Roche's drug for a chronic blood disorder RE
06-14 Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto DJ

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
US FDA approves Roche's drug for a chronic blood disorder
RE
Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer
MT
Amgen Inc. Announces U.S. Food and Drug Administration Approves Blincyto
CI
Sector Update: Health Care Stocks Softer Friday Afternoon
MT
Race Oncology Validates Efficacy of Blood Cancer Therapy in Animal Study; Shares Rise 6%
MT
Amgen Says Phase 3 Trial of Potential Autoimmune Disease Treatment Meets Endpoints
MT
Amgen's Uplizna Hits Phase 3 Endpoints in IgG4-RD
DJ
Amgen's drug meets main goal in late-stage study for rare disease
RE
Amgen Announces Positive Results for Phase 3 Registrational Trial Evaluating Uplizna® (Inebilizumab-Cdon) for Treatment of Immunoglobulin G4-Related Disease (Igg4-Rd)
CI
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
RE
Weight-loss drug forecasts jump to $150 billion as supply grows
RE
Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test
MT
Amgen and AstraZeneca's Lung Disease Drug Study Reports Mixed Results
MT
Amgen Announces the Results of the Phase 2a COURSE Trial Evaluating Tezspire® (Tezepelumab-Ekko) in People with Moderate to Very Severe Chronic Obstructive Pulmonary Disease
CI
US FDA approves Amgen drug for small cell lung cancer
RE
FDA Approves Amgen's IMDELLTRA?? (Tarlatamab-Llle) for the Treatment of Adult Patients with Extensive-Stage Small Cell Lung Cancer
CI
Amgen's Imdelltra Gets US FDA Accelerated Approval for Drug to Treat Extensive Stage Small Cell Lung Cancer
MT
US FDA approves Amgen drug for small cell lung cancer, Bloomberg News reports
RE
Health Care Climbs as Amgen Surges on Obesity-Drug Plans - Health Care Roundup
DJ
Apple Rally Helps Boost Equity Markets as Traders Parse Jobs Report
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AMGN Stock
  4. AMGN34 Stock
  5. News Amgen Inc.
  6. Highlights